BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23915977)

  • 1. MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.
    Akbari Moqadam F; Lange-Turenhout EA; Ariës IM; Pieters R; den Boer ML
    Leuk Res; 2013 Oct; 37(10):1315-21. PubMed ID: 23915977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-125b and miR-99a encoded on chromosome 21 co-regulate vincristine resistance in childhood acute megakaryoblastic leukemia.
    Kandi R; Gutti U; Saladi RG; Gutti RK
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):95-7. PubMed ID: 25571789
    [No Abstract]   [Full Text] [Related]  

  • 3. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
    Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
    Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia.
    Umerez M; Garcia-Obregon S; Martin-Guerrero I; Astigarraga I; Gutierrez-Camino A; Garcia-Orad A
    Pharmacogenomics; 2018 Mar; 19(4):361-373. PubMed ID: 29469670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [microRNA expression in childhood acute granulocytic leukemia and its subtypes].
    Luo XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang LD
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):831-5. PubMed ID: 22335948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.
    Mesrian Tanha H; Mojtabavi Naeini M; Rahgozar S; Moafi A; Honardoost MA
    Tumour Biol; 2016 Jun; 37(6):7861-72. PubMed ID: 26700663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
    Ju X; Li D; Shi Q; Hou H; Sun N; Shen B
    Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.
    Gefen N; Binder V; Zaliova M; Linka Y; Morrow M; Novosel A; Edry L; Hertzberg L; Shomron N; Williams O; Trka J; Borkhardt A; Izraeli S
    Leukemia; 2010 Jan; 24(1):89-96. PubMed ID: 19890372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA‑125b promotes leukemia cell resistance to daunorubicin by inhibiting apoptosis.
    Zhou L; Bai H; Wang C; Wei D; Qin Y; Xu X
    Mol Med Rep; 2014 May; 9(5):1909-16. PubMed ID: 24604579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building better therapy for children with acute lymphoblastic leukemia.
    Carroll WL; Raetz EA
    Cancer Cell; 2005 Apr; 7(4):289-91. PubMed ID: 15837616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic changes in a childhood acute lymphoblastic leukemia cell line during the adaptation to vincristine.
    Guzmán-Ortiz AL; Aparicio-Ozores G; Valle-Rios R; Medina-Contreras O; Patiño-López G; Quezada H
    Bol Med Hosp Infant Mex; 2017; 74(3):181-192. PubMed ID: 29382485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
    Zhuo L; Liu J; Wang B; Gao M; Huang A
    Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.
    Sun D; Layer R; Mueller AC; Cichewicz MA; Negishi M; Paschal BM; Dutta A
    Oncogene; 2014 Mar; 33(11):1448-57. PubMed ID: 23503464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
    Ghodousi ES; Aberuyi N; Rahgozar S
    Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
    Pouyanrad S; Rahgozar S; Ghodousi ES
    Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression and regulatory mechanism of microRNA-708 in pediatric common B-cell acute lymphoblastic leukemia].
    Li X; Li D; Zhuang Y; Shi Q; Wei W; Zhang H; Ju XL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):138-43. PubMed ID: 23611221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.
    Schotte D; Chau JC; Sylvester G; Liu G; Chen C; van der Velden VH; Broekhuis MJ; Peters TC; Pieters R; den Boer ML
    Leukemia; 2009 Feb; 23(2):313-22. PubMed ID: 18923441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
    Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
    J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
    Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
    Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.